UK needs to sharpen its act on home-brew guidance
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has acknowledged that there are still some shortcomings in its latest guidance to manufacturers on the modification of IVDs purchased from a third party, including when these are so altered that they may be considered as an entirely new product - as "home-brew" manufacture. It is planning to provide additional guidance to IVD users.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.